About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk

NCT01649661·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Memorial Sloan Kettering Cancer Center

With

National Cancer Institute (NCI)
University of Southern California
University of Toronto

Age

21–any

Sex

FEMALE

Healthy volunteers

Accepted

You may be eligible if

age 21 years or older
be a cancer-free pre- or postmenopausal woman
have no prior personal history of any cancer (including DCIS, excluding nonmelanoma skin-cancer)
able to speak and read English because the questionnaire is only available in English
able to provide informed consent

You may not be if

are pregnant at the time of MRI
have a prior personal history of any cancer (including DCIS, excluding nonmelanoma skin cancer)

The record

StatusCompleted

PhaseNo phase

Taking part437

StartedJul 2012

UpdatedJan 26, 2023

Conditions

Cancer Free Women

Where1

Memorial Sloan Kettering Cancer Center
New York, New York, United States

Clareo Health | MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk